Latest News about CYBN
Recent news which mentions CYBN
Psychedelic Stock Gainers And Losers From April 26, 2022
April 26, 2022
From Benzinga
From Benzinga
From Benzinga
Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage
April 25, 2022
From Benzinga
Cybin Presents "Why Cybin Is Investing So Heavily On Developing Novel Psychedelic Molecules" At The Psychedelic Capital Conference
April 25, 2022
Tickers
CYBN
From Benzinga
From Benzinga
Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp
April 22, 2022
Tickers
CYBN
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From April 20, 2022
April 20, 2022
From Benzinga
EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space
April 19, 2022
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
Psychedelic Stock Gainers And Losers From April 18, 2022
April 18, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From April 14, 2022
April 14, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From April 13, 2022
April 13, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From April 11, 2022
April 11, 2022
From Benzinga
From Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Strengthens IP Position Of Psychedelic Programs
April 08, 2022
Tickers
CYBN
From Benzinga
From Benzinga
Cybi (NEO: CYBN) (NYSE American: CYBN) To Participate In Benzinga Psychedelics Conference
April 07, 2022
Tickers
CYBN
From Benzinga
From Benzinga
From Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From April 5, 2022
April 05, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.